Objective: To analyze the effect of early screening and safe management of dysphagia in scleroderma patients. Methods: From January 2016 to January 2020, a randomized controlled trial was performed with scleroderma patients (n = 42) who were diagnosed as scleroderma. In intervention group, the participants are accepted early screening and safe management of swallowing disorders. The participants of control group are accepted common nursing service. Result: the 48.84% of participants have problems in swallowing process, most participants provide assessment of level 2 of WST. In swallowing test assessment, more participants think they feel obstruction when eating steamed bread. The accident aspiration pneumonia has higher risk than that of aspiration pneumonia in two group (10.00% vs 3.75% & 37.50% vs 23.75%). In research of swallowing function treatment, most participants of intervention group are basic recovery in treatment outcome, the control group have most invalid assessment in treatment outcome. Conclusion: the early screening and safe management of dysphagia can efficacy improve scleroderma dysphagia of scleroderma patients. In dysphagia problem, the scleroderma patients have higher risk of accident aspiration, and the early screening and safe management of dysphagia can improve problems of accident aspiration and aspiration pneumonia. Additionally, the early screening and safe management of dysphagia have strong effect for dysphagia.
| Published in | American Journal of Nursing Science (Volume 9, Issue 6) |
| DOI | 10.11648/j.ajns.20200906.20 |
| Page(s) | 442-444 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2020. Published by Science Publishing Group |
Scleroderma, Dysphagia, Nursing Intervention
| [1] | Alhajeri H, Hudson M, Fritzler M, Pope J, Tatibouet S, Markland J, et al. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Arthritis Care Res. 2015; 67 (4): 582–587. |
| [2] | Peytrignet S, Denton CP, Lunt M, Hesse strand R, Mouthon L, Silman A, Pan, X, et al. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European scleroderma observational study. Rheumatology. 2018; 57 (2): 370–381. |
| [3] | Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, et al. Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis. Nutrition. 2018: 55–56, 51–55. |
| [4] | Xu W, Zhang MJ. Progress in clinical manifestations, diagnosis and treatment of scleroderma digestive system involvement Chinese Clinical Medicine August. 2016; 23 (4): 519-524. |
| [5] | Malagelada JR, Bazzoli F, Boeckxstaens G, De Looze D, Fried M, Kahrilas P, Lindberg G, Malfertheiner P, Salis G, Sharma P, Sifrim D, Vakil N, Le Mair A. World Gastroenterology Organisation Global Guidelines: Dysphagia – Global Guidelines and Cascades Update September 2014. Journal of Clinical Gastroenterology. 2015; 49 (5): 370-378. |
| [6] | Baijens LWJ, Clavé P, Cras P, Ekberg O, Forster A, Kolb GF, Leners JC, Masiero S, Mateos-Nozal J, Ortega O, Smithard DG, Speyer R, Walshe M. European Society for Swallowing Disorders – European Union Geriatric Medicine Society white paper: oropharyngeal dysphagia as a geriatric syndrome. Clinical Interventions in Aging. 2016; 11: 1403-1428. |
| [7] | Namasivayam AM, Steele CM. Malnutrition and dysphagia in long term care: A systematic review. Journal of Nutrition in Gerontology and Geriatrics. 2015; 34 (1): 1-21. |
| [8] | Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: Its impact on diagnosis and treatment. Dysphagia. 2018; 17 (2): 139–146. |
| [9] | Cohen D, Roffe C, Beavan J, et al. Post-stroke dysphagia: a review and design con-side rations for future trials. Int J Stroke. 2016: 1–13. |
| [10] | Cui XX, Yang J, Tu WZ, LI M. Cutaneous manifestations and their clinical significance in patients with systemic sclerosis. Chinese Journal of Dermatology. 2016; 51 (01): 14-19. |
| [11] | Bours GJ, Speyer R, Lemmens J, Limburg M, de Wit R. Bedside screening tests vs. video fluoroscopy or fibreoptic endoscopic evaluation of swallowing to detect dysphagia in patients with neurological disorders: systematic review. J Adv Nurs. 2009; 65 (3): 477–493. |
| [12] | Chen PC, Chuang CH, Leong CP, Guo SE, Hsin YJ. Systematic review and meta-analysis of the diagnostic accuracy of the water swallow test for screening aspiration in stroke patients. J Adv Nurs. 2016; 72: 2575–86. |
| [13] | Wang Z, Yin X, Gao L, Feng S, Song K, Li L. The protective effect of hydrogen sulfide on systemic sclerosis associated skin and lung fibrosis in mice model. Springer plus. 2016; 5: 1084. |
| [14] | Koca SS, Ozgen M, Dagli AF, Gozel N, Ozercan IH, Isik A. The protective effects of Bevacizumab in bleomycin-induced experimental scleroderma. Adv. Clin. Exp. Med. 2016; 2: 249–253. |
| [15] | Knobler R, Moinzadeh P, Hunzelmann N, et al. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol: JEADV. 2017; 31 (10): 1581-1594. |
| [16] | Zhiwei H, Jimin W, Zhonghao W, Yu Z, Tao J, Chao Y, Xing D. Individualized treatment of severe gastroesophageal reflux disease caused by scleroderma: case and literature analysis [J]. Chinese journal of basic and clinical sciences. 2016; 23 (10): 1214-1219. |
APA Style
Yingfeng Huang, Guiyan Wen, Xia Huang, Xiaozhen Huang. (2020). Analysis on the Effect of Early Screening and Safe Management of Dysphagia in Scleroderma Patients. American Journal of Nursing Science, 9(6), 442-444. https://doi.org/10.11648/j.ajns.20200906.20
ACS Style
Yingfeng Huang; Guiyan Wen; Xia Huang; Xiaozhen Huang. Analysis on the Effect of Early Screening and Safe Management of Dysphagia in Scleroderma Patients. Am. J. Nurs. Sci. 2020, 9(6), 442-444. doi: 10.11648/j.ajns.20200906.20
AMA Style
Yingfeng Huang, Guiyan Wen, Xia Huang, Xiaozhen Huang. Analysis on the Effect of Early Screening and Safe Management of Dysphagia in Scleroderma Patients. Am J Nurs Sci. 2020;9(6):442-444. doi: 10.11648/j.ajns.20200906.20
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajns.20200906.20,
author = {Yingfeng Huang and Guiyan Wen and Xia Huang and Xiaozhen Huang},
title = {Analysis on the Effect of Early Screening and Safe Management of Dysphagia in Scleroderma Patients},
journal = {American Journal of Nursing Science},
volume = {9},
number = {6},
pages = {442-444},
doi = {10.11648/j.ajns.20200906.20},
url = {https://doi.org/10.11648/j.ajns.20200906.20},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajns.20200906.20},
abstract = {Objective: To analyze the effect of early screening and safe management of dysphagia in scleroderma patients. Methods: From January 2016 to January 2020, a randomized controlled trial was performed with scleroderma patients (n = 42) who were diagnosed as scleroderma. In intervention group, the participants are accepted early screening and safe management of swallowing disorders. The participants of control group are accepted common nursing service. Result: the 48.84% of participants have problems in swallowing process, most participants provide assessment of level 2 of WST. In swallowing test assessment, more participants think they feel obstruction when eating steamed bread. The accident aspiration pneumonia has higher risk than that of aspiration pneumonia in two group (10.00% vs 3.75% & 37.50% vs 23.75%). In research of swallowing function treatment, most participants of intervention group are basic recovery in treatment outcome, the control group have most invalid assessment in treatment outcome. Conclusion: the early screening and safe management of dysphagia can efficacy improve scleroderma dysphagia of scleroderma patients. In dysphagia problem, the scleroderma patients have higher risk of accident aspiration, and the early screening and safe management of dysphagia can improve problems of accident aspiration and aspiration pneumonia. Additionally, the early screening and safe management of dysphagia have strong effect for dysphagia.},
year = {2020}
}
TY - JOUR T1 - Analysis on the Effect of Early Screening and Safe Management of Dysphagia in Scleroderma Patients AU - Yingfeng Huang AU - Guiyan Wen AU - Xia Huang AU - Xiaozhen Huang Y1 - 2020/12/11 PY - 2020 N1 - https://doi.org/10.11648/j.ajns.20200906.20 DO - 10.11648/j.ajns.20200906.20 T2 - American Journal of Nursing Science JF - American Journal of Nursing Science JO - American Journal of Nursing Science SP - 442 EP - 444 PB - Science Publishing Group SN - 2328-5753 UR - https://doi.org/10.11648/j.ajns.20200906.20 AB - Objective: To analyze the effect of early screening and safe management of dysphagia in scleroderma patients. Methods: From January 2016 to January 2020, a randomized controlled trial was performed with scleroderma patients (n = 42) who were diagnosed as scleroderma. In intervention group, the participants are accepted early screening and safe management of swallowing disorders. The participants of control group are accepted common nursing service. Result: the 48.84% of participants have problems in swallowing process, most participants provide assessment of level 2 of WST. In swallowing test assessment, more participants think they feel obstruction when eating steamed bread. The accident aspiration pneumonia has higher risk than that of aspiration pneumonia in two group (10.00% vs 3.75% & 37.50% vs 23.75%). In research of swallowing function treatment, most participants of intervention group are basic recovery in treatment outcome, the control group have most invalid assessment in treatment outcome. Conclusion: the early screening and safe management of dysphagia can efficacy improve scleroderma dysphagia of scleroderma patients. In dysphagia problem, the scleroderma patients have higher risk of accident aspiration, and the early screening and safe management of dysphagia can improve problems of accident aspiration and aspiration pneumonia. Additionally, the early screening and safe management of dysphagia have strong effect for dysphagia. VL - 9 IS - 6 ER -
Information
Email: